Enzovel Tablet is a combination pharmaceutical formulation containing Bromelain (180 mg), Trypsin (96 mg), and Rutoside (200 mg), designed to provide potent anti-inflammatory, proteolytic, and vascular protective effects. Bromelain, a proteolytic enzyme derived from pineapple stems, facilitates the breakdown of proteins, thereby reducing inflammation and edema associated with trauma, surgery, and inflammatory conditions. Trypsin, another proteolytic enzyme, complements Bromelain by enhancing the degradation of inflammatory mediators and promoting tissue repair. Rutoside, a bioflavonoid, exerts antioxidant and vasoprotective properties by strengthening capillary walls, reducing capillary permeability, and preventing microvascular damage. The synergistic action of these components makes Enzovel Tablet effective in managing acute and chronic inflammatory disorders, including musculoskeletal injuries, postoperative swelling, and venous insufficiency. It is also beneficial in reducing pain and accelerating recovery by modulating the inflammatory response and improving microcirculation. Enzovel Tablet should be administered under medical supervision, with dosage tailored to the severity of the condition and patient response. Contraindications include hypersensitivity to any component and caution is advised in patients with bleeding disorders or those on anticoagulant therapy. Overall, Enzovel Tablet offers a comprehensive approach to inflammation management and vascular health support.